ArticleEuropean journal of clinical pharmacology2026

Comparing National Health Technology Assessment approaches and the new European Joint Clinical Assessment framework: The case of onco-hematological medicines.

Benedetta Starinieri et al.PubMed ↗Publisher ↗

No numbers read from the abstract.